Browse wiki

jump-to-nav Jump to: navigation, search
SE148:/MS1
MS Description BioSource amount<br /> We weighed 70 BioSource amount<br /> We weighed 70 mg dry weight (DW) of the lyophilized samples for CE-TOF-MS analysis, 5 mg DW for GC-TOF-MS analysis, 50 mg DW for LC-q-TOF-MS analysis to detect polar metabolites, and 15 mg DW for lipid profiling. <br /> <br /> Extraction for LC-q-TOF-MS to detect polar metabolites<br /> Fifty-mg DW of each sample was extracted in 50 volumes of extraction medium (methanol/water [2:5 v/v]) containing two reference compounds (0.5 mg/l flavonol-2’-sulfonic acid and1.0 mg/l ampicilin) using a mixer mill MM301 (Retsch) at a frequency of 20 Hz for 5 min at 4°C. After centrifugation for 10 min at 15,000 × g, the supernatant was transferred into a 2 ml tube. Thirty volumes of methanol were added to the tube and then extracted again using the mixer mill at a frequency of 20 Hz for 5 min at 4°C. After centrifugation for 10 min at 15,000 x g, the resulting supernatant was transferred into the tube. One hundred twenty-μl aliquot of the extracts was filtered using an Oasis® HLB μelusion plate (30 μm, Waters Co., Massachusetts, US). The extracts (100 μl) were transferred into a 2 ml tube and were evaporated to dryness in an SPD2010 SpeedVac® concentrator from ThermoSavant (Thermo Fisher Scientific). The extracts were dissolved by 100 μl of 20% aqueous methanol containing 0.5 mg l−1 lidocaine and 10-camphorsulfonic acid. <br /> <br /> LC-q-TOF-MS conditions to detect polar metabolites<br /> After preparation of the extracts, the sample extracts (1 μl) were analyzed using an LC-MS system equipped with an electrospray ionization (ESI) interface (LC, Waters Acquity UPLC system; MS, Waters Xevo G2 Q-Tof). The analytical conditions were as follows. LC: column, Acquity bridged ethyl hybrid (BEH) C18 (pore size 1.7 μm, length 2.1 × 100 mm, Waters); solvent system, solvent A (water containing 0.1% formic acid) and solvent B (acetonitrile with 0.1% formic acid); gradient program, 0.5% of solvent B at 0 min, 0.5% of solvent B at 0.1 min, 99.5% of solvent B at 12.0 min, 99.5% of solvent A and 0.5%B at 12.0 min, 0.5% of solvent B at 12.1 min, and 0.5% of solvent B at 15.0 min; flow rate, 0.3 ml/min; temperature, 40°C; MS detection: capillary voltage, +3.0 keV, cone voltage, 25.0 V, source temperature, 120°C, desolvation temperature, 450°C, cone gas flow, 50 l per h; desolvation gas flow, 800 l per h; collision energy, 6 V; mass range, m/z 100‒1500; scan duration, 0.1 sec; interscan delay, 0.014 sec; mode, centroid; polarity, positive; Lockspray (Leucine enkephalin): scan duration, 1.0 sec; interscan delay, 0.1 sec. The data were recorded using MassLynx version 4.1 software (Waters).<br /> version 4.1 software (Waters).<br />
MS ID MS1  +
MS Instrument LC, Waters Acquity UPLC system; MS, Waters Xevo G2 Q-Tof  +
MS Instrument Type UPLC-QTOF-MS  +
MS Ion Mode positive and negative  +
MS Ionization ESI  +
MS Title LC-q-TOF-MS  +
Modification dateThis property is a special property in this wiki. 24 April 2018 08:09:45  +
hide properties that link here 
  No properties link to this page.
 

 

Enter the name of the page to start browsing from.
Personal tools
View and Edit Metadata
Variants
Views
Actions
Toolbox